Congenital long-QT syndromes: a clinical and genetic update from infancy through adulthood
- PMID: 19185812
- PMCID: PMC4260467
- DOI: 10.1016/j.tcm.2008.11.002
Congenital long-QT syndromes: a clinical and genetic update from infancy through adulthood
Abstract
Long-QT syndromes (LQTSs) have been described in all ages and are a significant cause of cardiovascular mortality, especially in structurally normal hearts. Abnormalities in transmembrane ion conduction channels and structural proteins produce these clinical syndromes, labeled LQT1-LQT12; however, genotype-positive patients still represent only about 70% of LQTSs. Future research will determine the etiology of the remaining cases, further risk-stratify the known genetic defects, improve current treatment options for these syndromes, and uncover novel therapies.
Figures




References
-
- Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM. What clinicians should know about the QT interval. JAMA. 2003;289:2120–2127. - PubMed
-
- Atallah J, Fynn-Thompson F, Cecchin F, et al. Video-assisted thoracoscopic cardiac denervation: a potential novel therapeutic option for children with intractable ventricular arrhythmias. Ann Thorac Surg. 2008;86:1620–1625. - PubMed
-
- Berul CI, Sweeten TL, Dubin, et al. Use of the rate-corrected JT interval for prediction of repolarization abnormalities in children. Am J Cardiol. 1994;74:1254–1257. - PubMed
-
- Berul CI, Sweeten TL, Hill SL, Vetter VL. Provocative testing in children with suspect congenital long QT syndrome. Ann Noninvasive Electrocardiol. 1998;3:3–11.
-
- Crotti L, Spazzolini C, Schwartz PJ, et al. The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. Circulation. 2007;116:2366–2375. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources